Month: December 2022

Lead is known to harm children’s developing brains, and a recent study indicates that the consequences might last into old age. According to the study, lead exposure throughout childhood may result in lower cognitive abilities later in life, implying that people may develop dementia symptoms sooner. Although scientists have long known that lead exposure causes … Continue reading "Children Exposed to Lead may Experience Dementia Symptoms Earlier"

Viruses have been considered a controversial risk factor for Alzheimer’s for decades. It is a contentious hypothesis regarding the disease, frequently brushed aside by specialists as a dubious offshoot of accepted knowledge. However, research continued to establish whether they have a role in the development of Alzheimer’s. Two recent studies have lent some support to … Continue reading "More Evidence Suggests That Viruses Play a Role in Alzheimer’s"

The failure of a test medicine to reduce the Alzheimer’s course in international clinical trials has dealt another blow to hopes for a cure for the disease. The possible drug gantenerumab by Roche failed to slow clinical decline in patients with early Alzheimer’s in two phase-III trials. On November 14th, 2022, the Swiss pharmaceutical company … Continue reading "A Setback: Potential Alzheimer’s Drug Fails Roche Trial"